EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy

Michelle A Farrar, Didu Kariyawasam, Sarah Grattan, Klair Bayley, Mark Davis, Sandra Holland, Leigh B Waddel, Kristi Jones, Michelle Lorentzos, Anja Ravine, Tiffany Wotton, Veronica Wiley und 1 weitere

Journal of Neuromuscular Diseases · 03.01.2023 · 10 (1) · 15-28

DOI: 10.3233/jnd-221535 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuromuscular Diseases, online erschienen am 11.11.2022. Verfasst von Michelle A Farrar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Neurology, Sydney Children's Hospital Network, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A pilot newborn screening (NBS) program for Duchenne muscular dystrophy (DMD) study proposes to assess the feasibility of the screening procedure, temporal course of the various steps of screening, and the public acceptability of the program. This is particularly vital to ascertain as DMD is considered a ‘non-treatable’ disease and thus does not fit the traditional criteria for newborn screening. However, modern perspectives of NBS for DMD are changing and point to possible net benefits for children and their families undertaking NBS for DMD. The aim of this workshop was to establish pathways for the successful implementation and evaluation of a pilot NBS for DMD program in Australia. Consensus was reached as to the rationale for, potential benefits, risks, barriers and facilitators of screening, alongside the establishment of screening protocols and clinical referral pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneInfant, NewbornChildHumansNeonatal ScreeningAustraliaReferral and Consultation

Stichwörter der Autor:innen

Duchenne muscular dystrophyimplementationnewborn screeningpresymptomatictranslation

Autor:innen und Institutionen

  • Department of Paediatric Neurology, Sydney Children's Hospital Network, Sydney, NSW, Australia.
  • Discipline of Paediatrics, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, NSW, Australia.
  • Harry Perkins Institute of Medical Research, The University of Western Australia, Nedlands, WA, Australia.
  • Department of Diagnostic Genomics, PathWest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia.
  • Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Kids Neuroscience Centre, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Zitieren

APA

Farrar, M. A., Kariyawasam, D., Grattan, S., Bayley, K., Davis, M., Holland, S., Waddel, L. B., Jones, K., Lorentzos, M., Ravine, A., Wotton, T., Wiley, V., & DMD NBS Working Group (2023). Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases, 10(1), 15-28. https://doi.org/10.3233/jnd-221535

Vancouver

Farrar MA, Kariyawasam D, Grattan S, Bayley K, Davis M, Holland S, et al. Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. 2023;10(1):15-28. doi:10.3233/jnd-221535

BibTeX
@article{Farrar2023,
  author = {Farrar, Michelle A and Kariyawasam, Didu and Grattan, Sarah and Bayley, Klair and Davis, Mark and Holland, Sandra and Waddel, Leigh B and Jones, Kristi and Lorentzos, Michelle and Ravine, Anja and Wotton, Tiffany and Wiley, Veronica and DMD NBS Working Group, DMD NBS Working Group},
  title = {Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy},
  journal = {Journal of Neuromuscular Diseases},
  year = {2023},
  volume = {10},
  number = {1},
  pages = {15--28},
  doi = {10.3233/jnd-221535}
}
Kostenlos starten →